Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Center for Global Health and Medicine, Japan
An observational study to investigate the safety of maraviroc by examining whether there is bone metabolism dysfunction in actual use of maraviroc in human body, or not, measuring bone mineral density and markers for bone formation, desorption and chemokine.
Age
20–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Those whose primary care physician acknowledged the necessity of maraviroc treatment due to multi-resistance HIV strain that is confirmed to have CCR5 tropism.
Those who are willing and able to consent to this study
20 years old or older
You may not be if
Those who are not suited for maraviroc (whose HIV strain to be CXCR4 tropism)
Others who the principle investigator physician considered to be excluded
